Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT00619463
Other study ID # 1R49CE001171-01
Secondary ID
Status Completed
Phase N/A
First received February 11, 2008
Last updated September 23, 2013
Start date August 2007
Est. completion date October 2012

Study information

Verified date September 2013
Source Icahn School of Medicine at Mount Sinai
Contact n/a
Is FDA regulated No
Health authority United States: Institutional Review Board
Study type Interventional

Clinical Trial Summary

The purpose of the study is to determine the efficacy of aerobic exercise for improving cognition, mood, and fatigue after Traumatic Brain Injury (TBI) as well as examine the role of Brain Derived Neurotropic Factor (BDNF) and peripheral Vascular Endothelial Growth Factor (VEGF) as mediators of response to exercise.


Description:

The cognitive, emotional and physical effects of TBI are well documented in the literature. Specifically, reduced cognitive functioning and depression, which are much more prevalent than in the general population, represent key challenges in the rehabilitation of persons recovering from TBI. Aerobic exercise has been shown to improve cognition and mood in the general population. Although the positive effects of exercise have been known for some time, only recently have some of the mechanisms underlying these effects been defined. One hypothesized mechanism was that exercise elevates the levels of BDNF and VEGF in the CNS. Although research examining the effects of aerobic exercise in individuals with TBI is limited, exercise has been effective in improving cognition and depression in individuals with other medical conditions, such as cancer, multiple sclerosis, fibromyalgia, dementia, chronic fatigue syndrome, chronic obstructive pulmonary disease and the elderly.

The effects of aerobic exercise on patients with TBI will be examined in this clinical trial, using a crossover design with a wait-list control. The classic crossover design has been modified to examine the effects of an additional 8 weeks of exercise, for a total 16-week intervention, in one group. Participants will be randomized into one of two conditions: Group A - immediate eight weeks of intervention followed by monitoring or Group B - monitoring followed by 8 weeks of intervention. In addition, the participants in Group B will serve as their own controls to determine if another 8 weeks of exercise, for a total of 16 weeks, is necessary for cognitive improvement.

Each person will undergo individual interviews and testing/ questionnaires aimed at measuring cognition, mood, fatigue, and life satisfaction. Blood will be drawn 2 or 3 times to monitor BDNF and VEGF levels. Assessment of cognition, mood, fatigue and life satisfaction will occur at four time points for both groups.

It is hypothesized that aerobic exercise will result in improved cognition and mood from both subjective and objective perspectives. In addition, we will explore the effect of post-TBI exercise on community participation and life satisfaction and explore personal and injury characteristics that mediate effectiveness of aerobic exercise in individuals with TBI.


Recruitment information / eligibility

Status Completed
Enrollment 154
Est. completion date October 2012
Est. primary completion date October 2012
Accepts healthy volunteers No
Gender Both
Age group 18 Years and older
Eligibility Inclusion Criteria:

- Be 18 to 99

- Have experienced a TBI as a result of a blow to the head with a loss of consciousness or a period of being dazed and confused. This must be medically documented (e.g. EMS report, hospital record, physician record).

- Be at least six-months post-injury

- Be English-speaking since assessments and treatment sessions will be conducted by English-speaking therapists

- Have residential telephone service since follow up assessments may be completed via phone

- Live within 1.5 hours of NYC to be able to participate in baseline assessment and attend treatment sessions

- Provide written informed consent for participation

- Be willing to complete questionnaires and interviews about mood, thinking skills, fatigue, and life satisfaction

- Being willing to comply with protocol requirements and a schedule of exercise and assessments visits

- Being able to take part in a treadmill-based exercise program

Exclusion Criteria:

- Any medical condition in which exercising may be harmful, e.g., evidence of cardiovascular compromise including: history of acute myocardial infarction, history of coronary artery disease, unstable angina, uncontrolled hypertension, orthostatic hypotension, significant aortic valve disease, uncontrolled arrhythmia, uncompensated congestive heart failure, 3rd degree AV block without a pacemaker, active pericarditis, active myocarditis, or any evidence of pulmonary, endocrine or neurologic compromise; impaired left ventricular dysfunction; or syncopal episode within the past year

- Any medical condition requiring treatment with beta blockers or calcium channel blockers

- Under the age of 18 years of age

- Any clinically significant evidence of pulmonary, endocrine or neurologic (ataxia, gait disturbance, vertigo) compromise

- Resting pulse oxymetry of less than 95% oxygen (O2) saturation, in normal air

- Recent diagnosis of deep vein thrombosis or pulmonary embolism

- Active systemic illness or chronic infection that is not stable

- Active inflammatory process that is not stable

- Clinically significant anemia

- Clinically significant abnormal thyroid function tests

- Pregnant females

- Any reason that, in the investigator's opinion, makes the person unsuitable to participate

- Unable to physically participate in an exercise program

- Active participation in regular aerobic exercise in the six months prior to potential enrollment.

- Active substance abuse

Study Design

Allocation: Non-Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Crossover Assignment, Masking: Open Label, Primary Purpose: Treatment


Related Conditions & MeSH terms


Intervention

Behavioral:
Exercise
Eight weeks in an aerobic exercise program- 50 minutes of aerobic exercise on a treadmill - 3 days a week for 8 -16 weeks.
Exercise
Aerobic exercise program - 55 min aerobic exercise on the treadmill 3 days a week for either 8 or 16 weeks

Locations

Country Name City State
United States Icahn School of Medicine at Mount Sinai New York New York

Sponsors (3)

Lead Sponsor Collaborator
Icahn School of Medicine at Mount Sinai Centers for Disease Control and Prevention, U.S. Department of Education

Country where clinical trial is conducted

United States, 

Outcome

Type Measure Description Time frame Safety issue
Primary Hopkins Verbal Learning Test-Revised (HVLT-R) Every 8 weeks for 24 weeks No
Primary Trail Making Tests A and B (TMT) Every 8 weeks for 24 weeks No
Primary Digit span subtests of the WAIS-III Every 8 weeks for 24 weeks No
Primary Wisconsin card sort test (WCST) Every 8 weeks for 24 weeks No
Primary Controlled Oral Word Association Test (COWAT) Every 8 weeks for 24 weeks No
Primary Stroop Word Color Test Every 8 weeks for 24 weeks No
Primary Global Fatigue Index (GFI) Every 8 weeks for 24 Weeks. No
Primary Beck Depression Inventory-II ( BDI-II) Every 8 weeks for 24 Weeks. No
Primary Blood draws for assessment of BDNF and VEGF levels Every 8 weeks for 24 weeks No
Secondary Injury characteristics and demographic variables At the beginning of the study. Week 1 of 24 No
Secondary BISQ - Brain Injury Screening Questionnaire At the beginning of the study. Week 1 of 24 No
Secondary Life 3 Every 8 weeks for 24 Weeks No
Secondary Transition Measures Every 8 weeks for 24 Weeks No
Secondary University of Rhode Island Change Assessment (URICA) Every 8 weeks for 24 Weeks No
Secondary Exercise Diaries Once a day No
Secondary International Physical Activity Questionnaire (IPAQ) Once a week No
See also
  Status Clinical Trial Phase
Terminated NCT03052712 - Validation and Standardization of a Battery Evaluation of the Socio-emotional Functions in Various Neurological Pathologies N/A
Recruiting NCT05503316 - The Roll of Balance Confidence in Gait Rehabilitation in Persons With a Lesion of the Central Nervous System N/A
Completed NCT04356963 - Adjunct VR Pain Management in Acute Brain Injury N/A
Completed NCT03418129 - Neuromodulatory Treatments for Pain Management in TBI N/A
Terminated NCT03698747 - Myelin Imaging in Concussed High School Football Players
Recruiting NCT05130658 - Study to Improve Ambulation in Individuals With TBI Using Virtual Reality -Based Treadmill Training N/A
Recruiting NCT04560946 - Personalized, Augmented Cognitive Training (PACT) for Service Members and Veterans With a History of TBI N/A
Completed NCT05160194 - Gaining Real-Life Skills Over the Web N/A
Recruiting NCT02059941 - Managing Severe Traumatic Brain Injury (TBI) Without Intracranial Pressure Monitoring (ICP) Monitoring Guidelines N/A
Recruiting NCT03940443 - Differences in Mortality and Morbidity in Patients Suffering a Time-critical Condition Between GEMS and HEMS
Recruiting NCT03937947 - Traumatic Brain Injury Associated Radiological DVT Incidence and Significance Study
Completed NCT04465019 - Exoskeleton Rehabilitation on TBI
Recruiting NCT04530955 - Transitioning to a Valve-Gated Intrathecal Drug Delivery System (IDDS) N/A
Recruiting NCT03899532 - Remote Ischemic Conditioning in Traumatic Brain Injury N/A
Suspended NCT04244058 - Changes in Glutamatergic Neurotransmission of Severe TBI Patients Early Phase 1
Completed NCT03307070 - Adapted Cognitive Behavioral Treatment for Depression in Patients With Moderate to Severe Traumatic Brain Injury N/A
Recruiting NCT04274777 - The Relationship Between Lipid Peroxidation Products From Traumatic Brain Injury and Secondary Coagulation Disorders
Withdrawn NCT04199130 - Cognitive Rehabilitation and Brain Activity of Attention-Control Impairment in TBI N/A
Withdrawn NCT05062148 - Fundamental and Applied Concussion Recovery Modality Research and Development: Applications for the Enhanced Recovery N/A
Withdrawn NCT03626727 - Evaluation of the Efficacy of Sodium Oxybate (Xyrem®) in Treatment of Post-traumatic Narcolepsy and Post-traumatic Hypersomnia Early Phase 1